Search results
US FDA approves Bristol Myers' colorectal cancer therapy
Livemint· 6 days agoThe U.S. Food and Drug Administration has approved Bristol Myers Squibb's combination therapy for treating colorectal cancer in patients with a specific gene mutation, the health regulator said ...